Table 2. Univariate and multivariate Cox regression analyses of GAPLINC expression and clinical variables for overall survival of patients with CRC.
Variables | Categories | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | ||
Age (year) | >60/≤60 | 1.514 | 0.869–2.637 | 0.143 | |||
Sex | Maleemale | 0.974 | 0.642–1.475 | 0.905 | |||
Size (cm) | ≥5/<5 | 1.519 | 1.002–2.303 | 0.045* | 1.156 | 0.728–1.834 | 0.539 |
T stage | 1/2/3/4 | 2.153 | 1.534–3.021 | <0.01** | 1.222 | 0.668–2.233 | 0.516 |
N stage | N0/N1/N2 | 2.144 | 1.615–2.846 | <0.01** | 1.528 | 0.900–2.595 | 0.116 |
Grade | I/II/III | 2.789 | 1.575–4.940 | <0.01** | 1.972 | 1.197–3.250 | <0.01** |
GAPLINC | High / low | 2.730 | 1.771–4.207 | <0.01** | 2.214 | 1.375–3.565 | <0.01** |
Abbreviations: HR, hazard ratio; 95% CI, 95% confidence interval.
Statistically significant (P < 0.05).